Maze Therapeutics, Inc. Common Stock
MAZE • NASDAQ
Maze Therapeutics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Jason V. Coloma, with a market cap of $1.5B.
CEOJason V. Coloma
Market Cap$1.5B
Websitemazetx.com
Next Earnings
Upcoming earnings announcement for Maze Therapeutics, Inc. Common Stock
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.63
Revenue Estimate
$12.5M
Earnings History
Past 4 earnings reports for Maze Therapeutics, Inc. Common Stock
10-Q